Catalyst
Slingshot members are tracking this event:
Pain Therapeutics (PTIE) Plans to Resubmit NDA to FDA for Pain Medication REMOXY ER Following Abuse Potential Studies
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTIE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 13, 2018
Occurred Source:
http://investor.paintrials.com/news-releases/news-release-details/pain-therapeutics-resubmits-new-drug-application-remoxyr-er
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Abuse Potential Studies, Remoxy Er, Resubmission Of Nda
